SCHEMBL12435904

SCHEMBL12435904

COc1cc(OC(=O)c2ccc(CO)c(N)c2)cc(OC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TUBB4A P04350 2/20 0.49
TUBB P07437 2/20 0.49
TUBA3C P0DPH7 2/20 0.49
TUBA1B P68363 2/20 0.49
TUBA4A P68366 2/20 0.49
TUBB4B P68371 2/20 0.49
TUBB3 Q13509 2/20 0.49
TUBB2A Q13885 2/20 0.49
TUBB8 Q3ZCM7 2/20 0.49
TUBA3E Q6PEY2 2/20 0.49
TUBA1A Q71U36 2/20 0.49
TUBA1C Q9BQE3 2/20 0.49
TUBB6 Q9BUF5 2/20 0.49
TUBB2B Q9BVA1 2/20 0.49
TUBB1 Q9H4B7 2/20 0.49
MAPT P10636 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2216111 0.85 TUBB1 (0.67) KMT2AMEN1TSHRSMN1; SMN2TUBB4A
SCHEMBL17507473 0.83 MEN1 (0.54) KMT2AMEN1TSHRSMN1; SMN2TUBB4A
SCHEMBL12435914 0.81 KMT2A (0.46) KMT2AMEN1TUBB4ATUBBTUBA3C
SCHEMBL12435907 0.80 TUBB4A (0.49) KMT2AMEN1TSHRSMN1; SMN2TUBB4A
SCHEMBL12435906 0.80 LMNA (0.49) KMT2ATSHRSMN1; SMN2TUBB4ATUBB
SCHEMBL12436025 0.79 SMN1; SMN2 (0.46) KMT2AMEN1SMN1; SMN2TUBB4ATUBB
SCHEMBL12435910 0.79 KMT2A (0.44) KMT2AMEN1TSHRSMN1; SMN2MAPT
SCHEMBL12435902 0.79 ATM (0.56) KMT2AMEN1SMN1; SMN2TUBB4ATUBB
SCHEMBL12435918 0.78 KMT2A (0.43) KMT2AMEN1TSHRMAPTALDH1A1
SCHEMBL12435936 0.78 KMT2A (0.43) KMT2AMEN1TSHRMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use CUL3, APOBEC3G, BRPF3 KMT2A 964/4885MEN1 4747/4885TSHR 4577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.